XploSafe, a provider of critical safety solutions for homeland security and chemical safety, recently announced it has received a $2.47 million defense contract for its chemical-sensing wearable badges.
The contract was awarded by the U.S. Air Force Rapid Innovation Fund to XploSafe for
Avon Rubber is pleased to announce that Avon Protection has been awarded a 10-year contract by the NATO Support & Procurement Agency to supply FM50 mask systems, powered and supplied air systems, filters, spare parts and accessories.
SRI International has been awarded a contract of up to from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to support the research and development of radiation/nuclear medical countermeasures (MCMs). Under the contract, SRI
The microorganism that causes anthrax, the bacterium Bacillus anthracis, has infected people and animals since ancient times. Even though anthrax is rare, it is a severe infectious disease with a death rate ranging from 25% to 80% if medical treatment is not sought early. ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human
BioFactura, Inc. today announced a Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). The goal of this project is to develop,
The Defense Logistics Agency (DLA) recently awarded Federal Resources a multi-million dollar contract to provide over 4.5 billion gloves to America’s national strategic stockpile. Federal Resources Supply Company was selected by the DLA to continue delivering life-saving Personal Protective
Certain methods of decontaminating medical face masks for repeated use during the COVID-19 pandemic appear to damage the masks' integrity and protective function, according to research by a University of Massachusetts Amherst environmental health
INOVIO today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA® 3PSP smart device and the procurement of CELLECTRA® 2000 devices, which are
A household appliance, which may be sitting inside your kitchen cabinet, can now be used as a powerful tool in the fight to control COVID-19. Researchers with the Department of Homeland Security (DHS) ...
Due to the coronavirus pandemic, demand for protective face masks has sky-rocketed in recent months, as wearing masks is now a requirement along with social distancing and hygiene measures. A wide range of masks is available, with the leading model being the N95. The authorities insist on the
Bavarian Nordic announced today this month that the Company has entered into a new supply contract with Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson valued at USD 13.9 million.
SIGA Technologies, Inc. (SIGA) today announced that the United States Department of Defense (DoD), via the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological,
In a new study published this week in The Lancet, NIAID scientists describe the results of a small Phase 1 trial of a vaccine designed to provide broad protection against mosquito-borne diseases. The trial indicated that the vaccine is safe and induces a strong immune
The Director General of the International Atomic Energy Agency (IAEA), Rafael Mariano Grossi, launched an initiative today to strengthen global preparedness for future pandemics like COVID-19. The project, called ZODIAC, builds on the IAEA’s experience in assisting countries in the use of
Emergent BioSolutions Inc. announced on June 11th it will deploy its molecule-to-market contract development and manufacturing (CDMO) services to support the manufacturing of AstraZeneca’s vaccine candidate for COVID-19, AZD1222, a viral vector-based, weakened version of adenovirus containing
Blauer Manufacturing announced on June 11th that it received formal 3rd party certification for its new BIO-99™ coverall to the NFPA 1999 Standard on Protective Clothing and Ensembles for Emergency Medical Operations for multiple-use (...
Tiki was developed in Sweden, intended for use in demanding settings with the highest requirements of protection against airborne particles and bacteria. The Tiki mask is reusable, has self-adjusting ventilation and is operated with batteries. The
SIGA Technologies, Inc. today announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered to the Canadian Department of National Defence (CDND). On April 3, 2020, the Company previously announced that the CDND is expected to purchase up
Two Lawrence Livermore National Laboratory (LLNL) researchers who have worked for more than eight years to develop a tularemia vaccine are part of a three-institution team that has been funded to bring their candidate
A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.
Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.
After reaching a landmark agreement with the University of Oxford today for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2, AstraZeneca have now committed to at least 400 million
The isolation pod known as the EpiShuttle has finally reached France for evaluation from professional caretakers and medical transport. France is still comping with a large amount of corona patients and high rates of critical cases.
Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device
Federal Resources Supply Company was selected by the Defense Logistics Agency (DLA) to deliver kits of life-saving Personal Protective Equipment (PPE) to approximately 15,000 nursing homes across America. Responding to a request from the Federal Emergency Management Agency (FEMA) and in
On April 21 a joint Air Force team, led by the Air Force Life Cycle Management Center and the Air Force’s CBRN Defense Systems Branch, delivered a rapidly developed containment system prototype that will enable as many as 28 COVID-positive patients to be transported aboard a C-17 in response to
The University of Manchester is repurposing specialised equipment across its campus to help produce safety equipment for NHS workers battling COVID-19 in an attempt to help reduce the critical demand across the region.
In a combined effort with other universities, including Salford and
Biobeat, an end-to-end medical grade monitoring system for the management of patients and individuals from a distance is currently being utilised in 14 Israeli hospitals as the main monitoring solution in COVID-19 isolation units as part of the effort by the Israeli Ministry of Health to combat
Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.
PharmaJet, the maker of innovative, needle-free injection technology, announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for
Inovio Pharmaceuticals, USA has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV). This initial CEPI funding will support Inovio's